Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,108,037 | 1,791,517 | 1,541,048 | 1,800,808 | 1,142,281 |
| Marketable Securities | 654,102 | 549,021 | 647,872 | 312,761 | 911,387 |
| Receivables | 35,347 | 65,808 | 68,309 | 73,501 | 44,837 |
| Other current assets | 706,363 | 576,072 | 620,982 | 588,691 | 608,949 |
| TOTAL | $3,503,849 | $2,982,418 | $2,878,211 | $2,775,761 | $2,707,454 |
| Non-Current Assets | |||||
| PPE Net | 13,423,630 | 13,467,210 | 13,718,250 | 14,014,120 | 12,932,080 |
| Investments And Advances | 779,523 | 925,389 | 909,594 | 926,500 | 852,160 |
| Intangibles | 0 | 0 | 5,670 | 11,466 | 17,262 |
| Other Non-Current Assets | 33,407 | 3,871 | 4,136 | 4,514 | 5,958 |
| TOTAL | $14,236,560 | $14,396,470 | $14,637,650 | $14,956,600 | $13,807,460 |
| Total Assets | $17,740,410 | $17,378,890 | $17,515,870 | $17,732,360 | $16,514,910 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 128,165 | 122,672 | 113,554 | 128,322 | 131,085 |
| Accrued Expenses | 54,162 | 13,199 | 57,696 | 126,733 | 152,904 |
| TOTAL | $182,327 | $135,871 | $171,250 | $255,055 | $283,989 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,106,199 | 7,101,138 | 7,096,070 | 7,090,669 | 5,825,559 |
| Other Non-Current Liabilities | -143,393 | -76,322 | -45,767 | -119,867 | -365,979 |
| TOTAL | $7,149,899 | $7,101,138 | $7,096,070 | $7,090,669 | $5,825,559 |
| Total Liabilities | $7,332,226 | $7,237,009 | $7,267,320 | $7,345,724 | $6,109,548 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 607,220 | 607,178 | 607,176 | 607,174 | 607,172 |
| Common Shares | 107 | 106 | 106 | 106 | 105 |
| Retained earnings | 2,446,132 | 2,224,677 | 2,255,179 | 2,320,878 | 2,291,966 |
| Other shareholders' equity | 4,394,366 | 4,376,893 | 4,488,722 | 4,614,428 | 4,700,701 |
| TOTAL | $10,408,190 | $10,141,880 | $10,248,540 | $10,386,630 | $10,405,370 |
| Total Liabilities And Equity | $17,740,416 | $17,378,889 | $17,515,860 | $17,732,354 | $16,514,918 |